{
  "docId": "019dd923-605d-726d-81a5-9d02bdd33968",
  "docSlug": "bi-3a50f6764b9a5691",
  "documentTitle": "Pitch deck: Strive Health kidney care Series B led by CapitalG",
  "authorId": "Pitchdecks",
  "authorName": "Strive Health",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.785,
  "pageNumber": 6,
  "pageCount": 13,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The chart shows a breakdown of market spend by patient stage (CKD 3, CKD 4-5, ESRD) and segments (diagnosed vs undiagnosed).",
  "elementsJson": [
    "bar_chart_stacked",
    "bullet_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-605d-726d-81a5-9d02bdd33968/6",
  "deckHref": "/decks/019dd923-605d-726d-81a5-9d02bdd33968",
  "deckJsonHref": "/decks/019dd923-605d-726d-81a5-9d02bdd33968.json",
  "deckAnchorHref": "/decks/019dd923-605d-726d-81a5-9d02bdd33968#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.25,
        "x": 0.27,
        "y": 0.81
      },
      "kind": "callout",
      "text": "Incremental upside from servicing prevalent CKD Stage 1-2 patients is $200B",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "af352c71-695b-47f1-a25b-c60ba40e531b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.48,
        "x": 0.04,
        "y": 0.3
      },
      "kind": "chart",
      "text": "TAM for value-based renal care based on full capitation by patient stage",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "79660965-b3aa-4919-8527-cb16602832b0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.35,
        "x": 0.57,
        "y": 0.37
      },
      "kind": "list",
      "text": "Rise in comorbidities such as diabetes & hypertension\nAging population demographics\nDecreasing mortality rates\nPopulation growth",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "480607a9-600d-4578-b8e6-c0eac1c1d8f6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "TAM: $412B",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-b11c-744a-89d1-88efbf694357",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.12,
        "x": 0.04,
        "y": 0.91
      },
      "kind": "source-note",
      "text": "Source: LEK analysis.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fd17a889-58c0-4e4f-b55f-aa48dc9df7a4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.45,
        "x": 0.04,
        "y": 0.13
      },
      "kind": "title",
      "text": "The kidney care market is massive and expected to continue growing.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a7689142-a5dc-4946-a707-f6028e2f5c3a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Big Idea Formula",
      "slug": "big-idea-formula",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "d4444c40-3233-4407-91ea-a9502ac1f911",
      "evidence": "Incremental upside from servicing prevalent CKD Stage 1-2 patients is $200B",
      "confidence": 0.6
    },
    {
      "name": "Market Segmentation Pyramid",
      "slug": "market-segmentation-pyramid",
      "agent": null,
      "layer": "slide",
      "matchId": "36aa0ab9-f0bd-4a5d-8645-ac51831948d4",
      "evidence": "TAM for value-based renal care based on full capitation by patient stage",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 6,
      "from": 6,
      "beatId": "5c1afc54-ab0e-4322-a67d-a5072c4219b7",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Market Size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "The slide on market sizing aligns with this beat.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}